AtriCure ATRC

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$1.73 (-4.77%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of AtriCure (ATRC)
    AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $34.52

    • Market Cap

      $1.68 Billion

    • Price-Earnings Ratio

      -41.59

    • Total Outstanding Shares

      48.70 Million Shares

    • Total Employees

      1,200

    • Dividend

      No dividend

    • IPO Date

      August 5, 2005

    • SIC Description

      Surgical & Medical Instruments & Apparatus

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      7555 innovation way, Mason, OH, 45040

    • Homepage

      https://www.atricure.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow From Operating Activities, Continuing$10.40 Million
    Net Cash Flow From Operating Activities$10.40 Million
    Exchange Gains/Losses$180,000
    Net Cash Flow From Investing Activities$42.14 Million
    Net Cash Flow, Continuing$49.56 Million
    Net Cash Flow$49.74 Million

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Operating Income/Loss$-34.16 Million
    Benefits Costs and Expenses$485.36 Million
    Operating Expenses$368.88 Million
    Basic Earnings Per Share$-0.83
    Costs And Expenses$485.36 Million
    Cost Of Revenue$112.85 Million

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Parent$-36.88 Million
    Comprehensive Income/Loss$-36.88 Million
    Other Comprehensive Income/Loss Attributable To Parent$2.04 Million
    Other Comprehensive Income/Loss$-36.88 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Other Current Assets$192.74 Million
    Other Non-current Assets$287.43 Million
    Inventory$76.55 Million
    Other Non-current Liabilities$13.75 Million
    Noncurrent Assets$345.78 Million
    Accounts Payable$31.74 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ATRC from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.